Metabolic Mind6 Apr 2023

The Link between Insulin Resistance and Depression – An interview with Dr. Natalie Rasgon

Metabolic dysfunction, such as insulin resistance and pre-diabetes, is closely associated with symptoms of depression. But how do we know if metabolic dysfunction causes depression? Or if metabolic therapies could treat depression? Those are more difficult questions to answer, but there is accumulating biological evidence that links insulin resistance and depressive disorders.

Dr. Natalie Rasgon, a psychiatrist and clinician-researcher at Stanford University, published an important paper suggesting a possible causative role. Her research showed that measures of insulin resistance predicted the incidence of major depressive disorder. We discuss the background and findings of the study, as well as the take-home message–screening for and treating metabolic dysfunction can improve symptoms of depression.

Experts featured in this video: Natalie Rasgon, MD PhD Professor of Psychiatry and Behavioral Sciences at Stanford University https://profiles.stanford.edu/natalie-rasgon

Articles referenced in this video: Incident major depressive disorder predicted by three measures of insulin resistance: A Dutch cohort study https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2021.20101479

Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.

Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/

About us: Metabolic Mind™ is a nonprofit initiative incubated by Baszucki Group. Our mission is to provide education and resources in the emerging field of metabolic psychiatry, including ketogenic interventions for mental disorders. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #KetoForMentalHealth #MetabolicPsychiatry #BipolarTreatment #MetabolicNeuroscience #KetogenicMetabolicTherapy #DepressionTreatment#NutritionalKetosis#MentalIllnessTreatment#MentalHealthIsMetabolicHealth#BipolarDiet#insulinresistance #InsulinResistanceDepression#TreatmentResistantDepression

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(205)

New Study from 25-Year Eating Disorder Expert

Anorexia nervosa has one of the highest mortality rates of any psychiatric illness, yet effective biological treatments remain limited. For many people living with the condition, even after successful...

5 Jun 35min

First Keto Trial for Anorexia Nervosa: 72% Showed Recovery

A new study demonstrates that ketogenic therapy could be an option for individuals living with weight-normalized anorexia nervosa.One of the primary goals of anorexia nervosa treatment is restoring we...

3 Jun 3min

BITESIZE: New Study: Why Did This Drug Lower Cholesterol But Not Heart Plaque?

Lower triglycerides, lower remnant cholesterol, lower ApoB. Zero change in coronary artery plaque. A new clinical trial is forcing a bigger conversation about how we treat cardiovascular disease.The d...

1 Jun 3min

Keto as an Adjunct to CBTp? Nicole Laurent Explains

Could ketogenic therapy help people with schizophrenia spectrum disorders engage more successfully with CBT? A new conceptual framework explores this powerful adjunctive approach.CBTp is considered a ...

29 Mai 22min

Q&A: Keto for PCOS, Cravings, & Women’s Health with Temple Stewart

How many carbs should you eat on a ketogenic diet? Do ketone levels matter? And why do cravings hit so hard? Is Dairy recommended?In this Metabolic Mailbag episode, registered dietitian and medical st...

27 Mai 34min

GLP-1s, Weight Loss, and the Stigma We Don’t Talk About

A recent report highlighted a surprising trend: individuals using GLP-1 medications such as Ozempic and Wegovy may be facing even more social stigma than those who remain overweight. And while neither...

25 Mai 4min

APA Hallway Talk: Are Psych Meds Overprescribed?

Psychiatric medication tapering* is becoming one of the most important and controversial conversations in mental health care.In the wake of the American Psychiatric Association Annual Conference, Dr. ...

22 Mai 8min

Eggs and Alzheimer’s: New Study Challenges Assumptions

A new study suggests that eating more eggs may be linked to a lower risk of dementia. But what does the research actually show?Dr. Bret Scher breaks down the headlines, the limitations of observationa...

20 Mai 7min